MALABSORPTION FROM INJECTION SITE

This adverse event was reported 310 times

These drugs are most commonly taken by patients reporting MALABSORPTION FROM INJECTION SITE:

# Drug Count
0 HUMAN IMMUNOGLOBULIN G 56
1 INSULIN LISPRO 45
2 NALTREXONE 20
3 INSULIN GLARGINE 15
4 INSULIN HUMAN 15
5 TREPROSTINIL 12
6 ASPIRIN 11
7 LEVOTHYROXINE SODIUM 11
8 ASPIRIN 325 MG 10
9 ASPIRIN 81 MG 10
See all common drugs associated with MALABSORPTION FROM INJECTION SITE

MALABSORPTION FROM INJECTION SITE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 60 0.0028
1 Leptin Analog [EPC] 3 0.0024
2 Cytolytic Agent [EPC] 1 0.0004
3 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
4 Tissue-nonspecific Alkaline Phosphatase [EPC] 4 0.0004
5 Insulin [EPC] 17 0.0004
6 Ergot Derivative [EPC] 1 0.0002
7 Provitamin D2 Compound [EPC] 4 0.0001
8 Insulin Analog [EPC] 57 0.0001
9 Phenylalanine Metabolizing Enzyme [EPC] 1 0.0001
See all drug classes enriched for association with MALABSORPTION FROM INJECTION SITE